Stem Cell Market Research Reports & Industry Analysis
Cells must meet very specific criteria in order to be termed stem cells. They must: produce copies themselves; proliferate at a rapid rate; and display certain proteins on their surface that indicate a capacity to differentiate into other tissues, such as bone and cartilage. A stem cell line is a group of cells that all descend from a single original stem cell. Symmetric division gives rise to two identical daughter cells both endowed with stem cell properties. Asymmetric division produces only one stem cell and a progenitor cell with limited self-renewal potential.
Stem Cell Industry Research & Market Reports
-
Mesenchymal Stem Cells Market by Type (Allogeneic, Autologous), Indication (Bone & Cartilage Repair, Cancer, Cardiovascular Disease), Source of Isolation, Application - Global Forecast 2024-2030
... billion in 2023 and expected to reach USD 3.98 billion in 2024, at a CAGR 13.63% to reach USD 8.59 billion by 2030. Mesenchymal stem cells (MSCs) are multipotent stromal cells that can differentiate into ... Read More
-
Stem Cells Market by Type (Adult Stem Cell, Human Embryonic Stem Cell, Induced Pluripotent Stem Cell), Source (Allogenic, Autologous), Application, End-user - Global Forecast 2024-2030
... billion in 2023 and expected to reach USD 15.05 billion in 2024, at a CAGR 10.79% to reach USD 27.99 billion by 2030. The stem cell market comprises various products and services used for the ... Read More
-
Organoids Global Market Opportunities And Strategies To 2033 Including: 1) By Product: Hepatic Organoids; Colorectal Organoids; Intestinal Organoids 2) By Application: Developmental Biology; Disease Pathology Of Infectious Disease; Regenerative Medicine; Drug Toxicity And Efficacy Testing; Drug Discovery And Personalized Medicine 3) By End-Use Industries: Hospitals And Diagnostic Centers; Biopharmaceutical Companies; Academics And Research Institutes; Contract Research Organizations 4) By Source: Pluripotent Stem Cells; Organ-Specific Adult Stem Cells Covering: Thermo Fisher Scientific Inc.; Carl Zeiss AG; Corning Incorporated; Lonza Group Ltd.; STEMCELL Technologies Inc.
... from the COVID-19 shut down. Reasons to Purchase • Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies. • Understand how the market is being affected by ... Read More
-
Allogeneic Cell Therapy Market by Type (Chimeric Antigen Receptor T Cell Therapy, Hematopoietic Stem Cell Transplantation, Induced Pluripotent Stem Cell Therapy), Application (Hematological Disorders, Oncology, Regenerative Medicine), End-Use - Global Forecast 2024-2030
... Therapy Market size was estimated at USD 2.04 billion in 2023 and expected to reach USD 2.31 billion in 2024, at a CAGR 13.90% to reach USD 5.08 billion by 2030. Allogeneic cell therapy involves ... Read More
-
Regenerative Medicine Market by Product Type (Cell Therapy, Gene Therapy, Tissue Engineering, and Progenitor and Stem Cell Therapies), by Material (Synthetic Material, Biologically Derived Material, Genetically Engineered Material, and Pharmaceuticals), and by Application (Cardiovascular, Oncology, Dermatology, Musculoskeletal, Wound Healing, Ophthalmology, Neurology, and Others)– Global Opportunity Analysis and Industry Forecast, 2024 – 2030
... Dermatology, Musculoskeletal, Wound Healing, Ophthalmology, Neurology, and Others)– Global Opportunity Analysis and Industry Forecast, 2024 – 2030 The Regenerative Medicine Market size was valued at USD 24.85 billion in 2023, and is predicted to reach ... Read More
-
Global Viral Vector-Based Gene Therapy Drugs Market Growth (Status and Outlook) 2024-2030
... genetic disorders or diseases. These drugs typically contain modified viruses as vectors to efficiently and safely transfer genetic material into the cells of patients, aiming to correct genetic mutations or induce specific therapeutic effects. The ... Read More
-
Global Cord Blood Banking Service Market 2024 by Company, Regions, Type and Application, Forecast to 2030
... USD 46550 million in 2023 and is forecast to a readjusted size of USD 83970 million by 2030 with a CAGR of 8.8% during review period. According to our research, the global market for medical ... Read More
-
CAR T-Cell Therapy for Multiple Myeloma – Market Insight, Epidemiology, and Market Forecast – 2034
... understanding of the CAR T-Cell Therapy for Multiple Myeloma, historical and forecasted epidemiology as well as the CAR T-Cell Therapy for Multiple Myeloma market trends in the United States, EU5 (Germany, Spain, Italy, France, and ... Read More
-
Limbal Stem Cells Deficiency (lsd) – Market Insight, Epidemiology, and Market Forecast – 2034
... the Limbal Stem Cells Deficiency (lsd), historical and forecasted epidemiology as well as the Limbal Stem Cells Deficiency (lsd) market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan. ... Read More
-
Global Chronic Disease Management Therapeutics and Device Technologies Market Size study & Forecast, by Disease (Cardiovascular diseases (CVD), Diabetes, Cancer, Chronic respiratory diseases, Chronic kidney diseases, Neurological disorders, Others (such as autoimmune diseases, gastrointestinal disorders, and many)) by Therapy (Medications, Rehabilitation therapy, Behavioral therapy, Others (such as gene therapy, stem cell therapy, and many)), by Device (Blood glucose monitoring devices, Blood pressure monitors, Cardiac monitors, Respiratory therapy devices, Kidney dialysis machines, Neurostimulation devices, Others (such as insulin pumps, continuous glucose monitoring devices, and many)) and Regional Analysis, 2023-2030
... and many)) by Therapy (Medications, Rehabilitation therapy, Behavioral therapy, Others (such as gene therapy, stem cell therapy, and many)), by Device (Blood glucose monitoring devices, Blood pressure monitors, Cardiac monitors, Respiratory therapy devices, Kidney dialysis ... Read More
-
Cell and Gene Therapy Deals Analysis, 2021-2024
... in Q4 2024. Customers who purchase the report will receive both installments. Kalorama Information’s Cell and Gene Therapy Deals Analysis: Financings, Partnering, M&A, Tech Transfers, IPOs/SPACs, Other Deals, 2021-2024 offers a comprehensive look at the ... Read More
-
Allogeneic T-cell therapy for autoimmune diseases – Market Insight, Epidemiology, and Market Forecast – 2034
... understanding of the Allogeneic T-cell therapy for autoimmune diseases, historical and forecasted epidemiology as well as the Allogeneic T-cell therapy for autoimmune diseases market trends in the United States, EU5 (Germany, Spain, Italy, France, and ... Read More
-
Global CAR T-Cell therapy Market Size study & Forecast, by Indication (Lymphoma, Acute Lymphocytic Leukemia, Others), By Drug Type (Axicabtagene Ciloleucel, Tisagenlecleucel, Brexucabtagene Autoleucel, Others), By End user (Hospitals, Cancer Treatment Centers), and Regional Analysis, 2023-2030
... 2023-2030 Global CAR T-Cell therapy Market is valued at approximately USD 1.93 billion in 2022 and is anticipated to grow with a healthy growth rate of more than 13.5% over the forecast period 2023-2030. Chimeric ... Read More
-
Clinical Trials: Adoptive Cell Therapy
... such as sponsor type, therapy areas, location, and phase, are reviewed. Key Highlights A total of 42% of all adoptive cell therapy trials are ongoing. As most trials are ongoing, there may be an upcoming ... Read More
-
Corneal Transplant Market (Procedure Type: Penetrating Keratoplasty, Endothelial Keratoplasty, Descemet Stripping Automated Endothelial Keratoplasty (DSAEK), Corneal Graft, Corneal Limbal Stem Cell Transplant, and Others; and Indication: Fungal Corneal Ulcer, Bullous Keratopathy, Keratoconus, Keratitis, and Others) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2024-2034
... - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2024-2034 Corneal Transplant Market – Scope of Report TMR’s report on the global corneal transplant market studies the past as well as the current growth ... Read More
-
U.S. Non-alcoholic Steatohepatitis Biomarkers Market Size, Share & Trends Analysis Report By Type (Serum, Hepatic Fibrosis, Apoptosis), By End-use (Hospitals, Diagnostic Labs), And Segment Forecasts, 2024 - 2030
... Trends The U.S. non-alcoholic steatohepatitis biomarkers market size is anticipated to reach USD 2.84 billion by 2030 and is anticipated to expand at a CAGR of 23.9% from 2024 to 2030, according to a new ... Read More
-
Global Cell Isolation/Cell Separation Market [By Products (Consumables (Reagents & Kits, Beads, Disposables), Instruments (Magnetic Activated cell Separated, Filtration System, Centrifuge, Flow Cytometers)); By Technique (Centrifugation, Surface Marker, Filtration); By Cell Type (Human Cell Type (Differentiated Cells, Stem Cells), Animals cells); By Application (Biomolecule Isolation, Therapeutics, Cancer Research, In Vitro Diagnostics, Stem Cell Research); By End Use (Research Laboratories, Cell Banks, Biotechnology and Biopharmaceutical Companies, Hospitals and Diagnostics Laboratories); By Region]: Market Size & Forecast, 2024 – 2032
... (Differentiated Cells, Stem Cells), Animals cells); By Application (Biomolecule Isolation, Therapeutics, Cancer Research, In Vitro Diagnostics, Stem Cell Research); By End Use (Research Laboratories, Cell Banks, Biotechnology and Biopharmaceutical Companies, Hospitals and Diagnostics Laboratories); By ... Read More
-
3D Cell Culture Market [By Product Type (Scaffold based platforms, Bioreactors, Gels, Microchips, Services); By Application (Drug Discovery, Stem cell research, Cancer research, Regenerative medicine); By End-User (Academic Institutes, Biotechnology & Pharmaceutical Companies, Contract Research Laboratories); and By Regions (North America - U.S., Canada; Europe - Germany, UK, France, Italy, Russia; Asia-Pacific - China, India, Japan, Australia; Latin America - Brazil, Mexico; Middle East & Africa)]: Market size & Forecast, 2024 – 2032
... Laboratories); and By Regions (North America - U.S., Canada; Europe - Germany, UK, France, Italy, Russia; Asia-Pacific - China, India, Japan, Australia; Latin America - Brazil, Mexico; Middle East & Africa)]: Market size & Forecast, ... Read More
-
Induced Pluripotent Stem Cell (iPSC) Market Share, Size, Trends, Industry Analysis Report, By Derived Cell (Hepatocytes, Fibroblasts, Neural Cells, Amniotic Cells, Cardiomyocytes, Others); By Workflow; By Application; By Region; Segment Forecast, 2024 - 2032
... global Induced Pluripotent Stem Cell (iPSC) market size is expected to reach USD 4,355.56 Million by 2032, according to a new study by Polaris Market Research. The report “iPSC Market Share, Size, Trends, Industry Analysis ... Read More
-
Induced Pluripotent Stem Cell (iPSC) Market Share, Size, Trends, Industry Analysis Report, By Derived Cell (Hepatocytes, Fibroblasts, Neural Cells, Amniotic Cells, Cardiomyocytes, Others); By Workflow; By Application; By Region; Segment Forecast, 2024 - 2032
... global Induced Pluripotent Stem Cell (iPSC) market size is expected to reach USD 4,355.56 Million by 2032, according to a new study by Polaris Market Research. The report “iPSC Market Share, Size, Trends, Industry Analysis ... Read More
-
Europe Induced Pluripotent Stem Cell (iPSC) Market Share, Size, Trends, Industry Analysis Report, By Derived Cell; By Workflow (Reprogramming, Cell Culture, Cell Characterization, Engineering, Others); By Application; By Country; Segment Forecast, 2024 - 2032
... Europe Induced Pluripotent Stem Cell (iPSC) market size is expected to reach USD 1,111.97 Million by 2032, according to a new study by Polaris Market Research. The report “Europe Induced Pluripotent Stem Cell (iPSC) Market ... Read More
-
Biopreservation Market by Product (Media [Cryopreservation, Hypothermic]), Equipment (Freezers, Refrigerators, Incubators, Centrifuge, Accessories), Biospecimen (Tissues, Organs, Stem Cells), Application (Research, Therapeutic) - Global Forecast to 2029
... 7.1 billion by 2029 from USD 4.4 billion in 2024, at a CAGR of 9.8% during the forecast period. The growth of this market is majorly driven by rise in demand for preserving biological materials ... Read More
-
U.S. Induced Pluripotent Stem Cell (iPSC) Market Share, Size, Trends, Industry Analysis Report, By Derived Cell (Hepatocytes, Fibroblasts, Neural Cells, Amniotic Cells, Cardiomyocytes, Others); By Workflow; By Application; Segment Forecast, 2024 - 2032
... Induced Pluripotent Stem Cell (iPSC) market size is expected to reach USD 4,355.56 Million by 2032, according to a new study by Polaris Market Research. The report “iPSC Market Share, Size, Trends, Industry Analysis Report, ... Read More
-
Stem Cell Therapy Market, By Cell Source (Adult Stem Cells, Induced Pluripotent Stem Cells, Embryonic Stem Cells, Others), By Application (Musculoskeletal Disorders, Wounds and Injuries, Cancer, Autoimmune Disorders, Others), By End User (Hospitals, Cell Banks , Academic and Research Institutes), By Geography (North America, Latin America, Europe, Asia Pacific, Middle East & Africa)
... , Academic and Research Institutes), By Geography (North America, Latin America, Europe, Asia Pacific, Middle East & Africa) Stem cell therapy is a promising and emerging field in regenerative medicine that involves the use of ... Read More
-
Europe Hair Restoration Market Size study, by Recipient Area (Scalp, and Non-scalp), by Treatment (Follicular Unit Extraction (FUE), Follicular Unit Transplant (FUT), Laser Therapy, Stem Cell Therapy, and Other Treatments), by End-User (Hospitals, Clinics, and Others) and Country Forecasts 2022-2032
... Others) and Country Forecasts 2022-2032 Europe Hair Restoration Market is valued at approximately USD 1.37 billion in 2023 and is anticipated to grow with a healthy growth rate of more than 16.29% over the forecast ... Read More